Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study

Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study

Abstract Background Denosumab is a major treatment option for patients with postmenopausal osteoporosis; however, the evidence for its use is lacking. Therefore, in this 24-month retrospective study, we aimed to evaluate the effects of switching from minodronate (MIN) to denosumab in these patients....

Full description

Bibliographic Details
Main Authors: Masaki Kobayashi, Kenjiro Sawada, Akihiko Yoshimura, Misa Yamamoto, Aasa Shimizu, Kotaro Shimura, Naoko Komura, Mayuko Miyamoto, Kyoso Ishida, Tadashi Kimura
Format: Article
Language:English
Published: BMC 2020-03-01
Series:BMC Women's Health
Subjects:
Postmenopausal osteoporosis
Denosumab
Minodronate
Switching therapy
Online Access:http://link.springer.com/article/10.1186/s12905-020-00913-x

Internet

http://link.springer.com/article/10.1186/s12905-020-00913-x

Similar Items